Panel To Decide On Valsartan MDL, Whether To Limit It To Economic Injuries
WASHINGTON, D.C. — A federal judicial panel will hear arguments Jan. 31 on whether to consolidate 11 federal valsartan lawsuits in a multidistrict litigation and, if so, whether the MDL should...To view the full article, register now.
Already a subscriber? Click here to view full article